ABSTRAn. The ability of the third generation cephalosporins to penetrate human polymorphonuclear leukocytes (PMNs) and their antibacterial activity against cell-associated Staphylococcus aureus (SA) and Haemophilus influenza, type b (Hib) were studied. Utilizing radioactive uptake experiments, the cellular to extracellular concentration ratios were determined to be less than one for all cephalosporins at 10 Although each third generation cephalosporin showed good activity against cell-associated Hib, chloramphenicol had a significantly greater effect ( p < 0.05). N-formimidoyl thienamycin demonstrated good activity only after the concentration was increased in vitro to 8 pg/ml. Although cellular penetration of antibiotics may be important in the eradication of cell-associated pathogens, the overall cellular activity would appear to be multifactorial. (Pediatr Res 20:909-912,1986) Abbreviations SA, Staphylococcus aureus Hib, Haemophilus influenzae, type b cfu, colony forming unit cpm, counts per minute HBSS, Hanks' balanced salt solution GBSS, Geys balanced salt solution PMN, polymorphonuclear leukocytes MIC, minimum inhibitory concentration MBC, minimum bactericidal concentration C/E, cellular to extracellular concentration ratio SpAc, specific activity Bacterial pathogens that are capable of survival and replication intracellularly are a significant cause of human infections; path-ogens that have been demonstrated to be "cell-associated" in human disease and experimental infections may also be clinically significant (1) (2) (3) (4) . If these pathogens are capable of intracellular survival, they may evade killing by antibiotics that do not enter phagocytic cells (5) (6) (7) (8) (9) .
The newer P-lactam antibiotics have been shown to have marked activity against Hib and good (although variable) activity against may strains of SA (10) . We evaluated the ability of these antibiotics to penetrate PMNs and kill cell-associated SA and Hib.
METHODS
PMN isolation. PMNs were obtained from whole blood of adult donors free of infection and antibiotics. Heparinized (20 U/ml) blood was added to dextran (Macrodex, 6% w/v, in saline, Pharmacia Laboratories, Piscataway, NJ) at a ratio of 5 ml blood: 1 ml dextran and was allowed to sediment in an upright position until the erythrocytes settled to 50% of the total volume. The harvested leukocyte-rich-plasma supernate was washed in HBSS without Ca" and Mg++ (Grand Island Biological Co, Gibco; Grand Island, NY) by centrifugation at 300 x g for 7 min. The cell button was incubated in 0.84% NH4C1 at 37" C X 5 rnin to lyse retained erythrocytes and washed in HBSS at 300 x g for 7 min. The PMN fraction was isolated by centrifugation of the leukocyte button resuspended in HBSS at 500 x g for 30 rnin over Ficoll-Hypaque, specific gravity 1.077 (Sigma Chemical Co., St. Louis, MO). The PMNs were washed twice in HBSS at 300 x g for 7 min, resuspended in RPMI 1640 (Gibco) and counted in a hemacytometer. Viability as determined by trypan blue dye exclusion was consistently >97%.
Uptake of antibiotics by PMNs. PMN penetration by cefotaxime, ceftizoxime, ceftriaxone, and N-formimidoyl thienamycin was assayed as previously described (5,6, 1 1). Each reaction tube contained 1 ml of 5 X lo6 PMN in RPMI 1640 with 10% fetal calf serum (Gibco) and 100 p1 of one of the following in RPMI 1640 yielding a final concentration as listed: 8 pCi/ml [3H] H 2 0 (SpAc-100 pCi/ml, New England Nuclear, Boston, MA), 44 pCi/ml Naz3304 (SpAc-500 pCi/ml, New England Nuclear), 5 pCi/ml [I4C] cefotaxime (SpAc-100 pCi/ml, Hoechst, Frankfort, Germany), 5 pCi/ml [I4C] ceftizoxime (SpAc-17.2 mCi/ mmol, Smith, Kline, and French, Philadelphia, PA), 5 pCi/ml [I4C] ceftriaxone (SpAc-100 pCi/ml, Hoffman-LaRoche, Nutley, NJ), 5 pCi/ml N-formimidoyl thienamycin (SpAc-0.4 mCil29.4 mg, Merck, Sharpe, and Dohme, Rahway, NJ), 5 pCi/ ml [3H] clindamycin (SpAc-50 pCi/ml, UpJohn Co, Kalamazoo, MI), or 5 pCi/ml [I4C] penicillin (SpAc-25 pCi/ml, New England Nuclear). The reaction mixtures were incubated in a 37" C shaking water bath at 200 rpm. At 10 and 120 min a 500-pl aliquot of each was removed, layered over 1 ml inert silicone oil (Versilube, General Electric Co, Schenectady, NY), and centrifuged at 10,000 X g for 2 rnin in a microcentrifuge (Eppendorf, Brinkman Electronics, Westburg, NY). The radioactivity of the 1, 14) . There was a decrease of 5 0.5 log in the number of cfulml in the antibiotic-free PMN reaction mixtures (cell control) over the 4-h incubation for SA and Hib. All data in Figures 1 and 2 are shown as the fraction survival (percent) of SA and Hib in assays with PMNs plus antibiotics compared to parallel cfulml in tubes with PMNs that did not contain antibiotics at each time point (corrected fraction survival). In the SA assays, all drug concentrations used were equal to the MBC except clindamycin and N-formimidoyl thienamycin. The effect of twice the MBC of clindamycin was similar to the results at the MBC (data not shown), and the higher concentration which is easily acheivable in humans was investigated to evaluate for an enhanced effect. When tested at the same multiples of the MBC, N-formimidoyl thienamycin (MBC, 2 x MBC) was found to have activity comparable to third generation cephalosporins (MBC) and less activity than clindamycin (MBC; data not shown). However, the higher concentrations of Nformimidoyl thienamycin (5 x MBC), which are within the clinically achievable range, demonstrated substantial activity similar to that seen with the lower concentration (MBC) of clindamycin (Fig. I ). In the Hib assays, no effect on Hib viability was seen with ampicillin, cefotaxime, ceftizoxime, ceftriaxone, or N-formimidoyl thienamycin at concentrations equal to the respective MBCs. The concentrations of four to 15 times the MBC were chosen to demonstrate effect and to represent achievable concentrations in patient compartments. higher with nafcillin (4 pglml; p < 0.05) and significantly lower with clindamycin (2 pg/ml; p < 0.01) and N-formimidoyl thienamycin (1 pg/ ml; p < 0.01) compared to other P-lactam antibiotics. In Figure 1 , the effect of antibiotics on cell-associated SA demonstrated a lack of effective killing by nafcillin (fraction survival: 88 f 8%, 81 f 13%, 71 f 19% at 0.5, 2, 4 h, respectively; p < 0.05, compared to all other antibiotics) and the efficient killing of cell-associated SA by clindamycin (fraction survival: 9.7 f 5.1%, 10.3 f 2.4%, 8.1 + 5.1% at 0.5, 2, 4 h, respectively, p < 0.01, compared to all drugs except N-formimidoyl thienamycin). The increased killing of cell-associated SA by N-formimidoyl thienamycin (fraction survival: 13.9 f 4.1 %, 7.4 f 2.2%, 9.9 + 6.3% at 0.5, 2, 4 h, respectively) was significantly greater ( p < 0.01) than the other P-lactam drugs and probably reflects the increased susceptibility (MICIMBC: 0.110.2 pglml) of SA for the concentration of N-formimidoyl thienamycin in the reaction mixtures (1 pglml; 5-to 10-fold higher concentration). This killing, however, was only seen at a concentration five times the MBC of the organism. The killing of cell-associated SA by gentamicin, cefotaxime, ceftizoxime, and ceftriaxone were similar at all times points and was significantly greater then nafcillin (p < 0.05) with the exception of ceftriaxone at 0.5 and 4.0 h ( p > 0.05; Fig. 1 ).
In Figure 2 , the effect of antibiotics on cell-associated Hib are shown. The excellent penetration of the lipophilic antibiotic, chloramphenicol, in combination with its bactericidal activity against Hib produced significant killing (fraction survival, 8 pg/ ml: 9 f 6%, 4 f 3%, 1 + 1% at 0.5,2,4 h, respectively) compared to all other antibiotics ( p < 0.05, Fig. 2 ). Of note, the cellassociated killing by chloramphenicol(2 pglml, MBC concentration) was similar to ampicillin (8 pglml, >20-fold the MBC) at 0.5 and 2 h; the cell-associated killing was significantly less at 4 h with ampicillin (22 + 7%) than with 2 pglml chloramphenicol (1 1 f 6%, p < 0.05). The killing of cell-associated Hib by 9 12 JACOBS ET AL. cefotaxime, ceftizoxime, and ceftriaxone was significantly greater than ampicillin at all time points (p < 0.05; Fig. 2 ) even at a concentration of 0.5 pg/ml and probably reflected the lower MBC (0.03 pg/ml) for these antibiotics. A concentration of 8 pg/ ml of N-formimidoyl thienamycin was required before comparable killing was observed (Fig. 2) . N-formimidoyl thienamycin (2 pg/ml; MBC-2 pg/ml) did not effectively kill cell-associated Hib (fraction survival: 96 f 32%, 92 + 2796, 70 f 20% at 0.5, 2, 4 h, respectively) compared to all other antibiotics and probably reflects the degree of penetration into PMNs coupled with a higher MBC compared to the other p-lactam antibiotics.
DISCUSSION
The significance of in vitro antibiotic penetration and intracellular killing has some clinical correlates for support (2, 8, 9) . The question of whether or not cell-associated organisms actually occupy an intracellular location has been a criticism of in vitro phagocyte research for several years. In previous experiments, we have performed phase contrast and electron microscopy to demonstrate the intracellular location of Hib and SA in this assay system (5, 14) .
We and others have demonstrated that hydrophilic antibiotics such as penicillin do not penetrate phagocytes and that lipophilic antibiotics such as chloramphenicol and clindamycin penetrate and are concentrated in phagocytes ( 5 , 6 , 1 1, [16] [17] [18] . The activity of antibiotics that penetrate normal and chronic granulomatous disease PMNs against cell-associated bacteria has been demonstrated in vitro to be significantly greater than antibiotics that are excluded from PMNs (6, 19, 20) . The newer p-lactam antibiotics, cefotaxime, ceftizoxime, ceftriaxone, and N-formimidoyl thienamycin (Imipenem), are similar to penicillin in their relative inability to penetrate PMNs.
The killing of cell-associated SA was enhanced with clindamycin and not nafcillin, as previously described (6, 11) . The activity of gentamicin in this situation has been described as poor (6, 11) and intermediate in these experiments. It was not comparable to clindamycin. The third generation cephalosporins showed intermediate activity against cell-associated SA that was susceptible to these compounds by MIC/MBC testing. N-formimidoyl thienamycin was, however, found to be very effective in these experiments against SA, but the concentration required was higher in comparison to achievable serum concentrations of the third generation cephalosporins. These observations may be a demonstration of the increased susceptibility of most strains of SA against this antibiotic (2 1); the MIC/MBC for this strain was less than for the third generation cephalosporins. However, enhanced killing of cell-associated SA was seen only at concentrations five times the MBC. The potential clinical importance of this effect may be seen only in those patients in which higher serum concentrations of N-formimidoyl thienamycin are achieved. There were no significant differences in killing of cellassociated SA by cefotaxime or ceftizoxime; ceftriaxone demonstrated comparable activity but was not significantly greater than nafcillin at 0.5 and 4 h.
The analysis of cell-associated killing of Hib demonstrated again that chloramphenicol is superior in its intracellular activity due at least in part to its penetrating potential. There was increased activity of cefotaxime, ceftizoxime, and ceftriaxone against cell-associated Hib compared to drug free controls. This increased activity probably reflects the marked susceptibility of Hib for these antibiotics. A concentration of ampicillin approximately 26 times the MBC was required to produce killing comparable to 0.5 pg/ml of these antibiotics (approximately 17 times the MBC). Of interest, N-formimidoyl thienamycin with a higher MBC (2.0 pg/ml) demonstrated poor killing at 2 pg/ml and required 8 pg/ml (four times the MBC) to kill comparable numbers of cell-associated Hib. This lack of significant killing of cell-associated Hib by an antibiotic that penetrates phagocytes poorly and is at an extracellular concentration equal to the MBC supports the intracellular location of the organisms and the significance of phagocyte penetration in eradicating these organisms.
The issue of intracellular activity of antibiotics is probably multifactorial and effective antimicrobial activity may require a bactericidal drug that is capable of acheiving therapeutic concentrations in the appropriate compartment ('joint fluid, cerebrospinal fluid) as well as the ability to penetrate phagocytes in a bioactive form. These data support the importance of both the extracellular concentration of the drug relative to the MBC of the organism and the intracellular/extracellular concentration ratio as determinants of effectiveness intracellulary.
In summary,' we have demonstrated that newer p-lactam antibiotics do not efficiently penetrate PMNs. The intracellular activity of these antibiotics is directly effected by the susceptibility of the organism and the ability of these antibiotics to penetrate the cell. The clinical significance of intracellular activity of newer p-lactam antibiotics awaits further experience against susceptible bacteria capable of survival within phagocytic cells.
